Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 18 studies | 40% ± 21% | |
lung | 10 studies | 23% ± 8% | |
peripheral blood | 9 studies | 22% ± 8% | |
eye | 8 studies | 27% ± 12% | |
heart | 5 studies | 29% ± 8% | |
liver | 5 studies | 28% ± 13% | |
adipose | 4 studies | 34% ± 14% | |
intestine | 3 studies | 23% ± 7% | |
kidney | 3 studies | 29% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4785.34 | 1445 / 1445 | 100% | 28.23 | 183 / 183 |
breast | 100% | 4194.01 | 459 / 459 | 100% | 29.03 | 1116 / 1118 |
thymus | 100% | 5719.77 | 653 / 653 | 99% | 20.71 | 601 / 605 |
ovary | 100% | 4718.02 | 180 / 180 | 99% | 19.91 | 427 / 430 |
stomach | 100% | 3530.36 | 359 / 359 | 99% | 19.32 | 284 / 286 |
prostate | 100% | 4395.68 | 245 / 245 | 99% | 17.99 | 498 / 502 |
intestine | 100% | 4985.81 | 966 / 966 | 99% | 17.26 | 522 / 527 |
uterus | 100% | 5372.15 | 170 / 170 | 99% | 21.19 | 453 / 459 |
lung | 100% | 4127.80 | 578 / 578 | 99% | 18.21 | 1139 / 1155 |
brain | 100% | 3752.18 | 2630 / 2642 | 99% | 17.61 | 697 / 705 |
skin | 100% | 5772.24 | 1809 / 1809 | 98% | 18.88 | 464 / 472 |
pancreas | 100% | 3098.06 | 327 / 328 | 98% | 15.60 | 174 / 178 |
bladder | 100% | 4213.57 | 21 / 21 | 97% | 14.71 | 491 / 504 |
kidney | 100% | 3473.51 | 89 / 89 | 96% | 15.96 | 865 / 901 |
adrenal gland | 100% | 3856.78 | 257 / 258 | 90% | 9.97 | 208 / 230 |
liver | 100% | 1849.64 | 225 / 226 | 81% | 8.06 | 328 / 406 |
adipose | 100% | 3992.63 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 4106.35 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 20.26 | 29 / 29 |
spleen | 100% | 5070.55 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 26.76 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.27 | 1 / 1 |
muscle | 100% | 4200.16 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 2524.89 | 831 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 12.03 | 77 / 80 |
peripheral blood | 96% | 3584.26 | 894 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1903025 | Biological process | regulation of RNA polymerase II regulatory region sequence-specific DNA binding |
GO_0033135 | Biological process | regulation of peptidyl-serine phosphorylation |
GO_0032259 | Biological process | methylation |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0006338 | Biological process | chromatin remodeling |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0046966 | Molecular function | nuclear thyroid hormone receptor binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0003682 | Molecular function | chromatin binding |
GO_0140954 | Molecular function | histone H3K36 dimethyltransferase activity |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0003712 | Molecular function | transcription coregulator activity |
GO_0030331 | Molecular function | nuclear estrogen receptor binding |
GO_0046965 | Molecular function | nuclear retinoid X receptor binding |
GO_0042974 | Molecular function | nuclear retinoic acid receptor binding |
GO_0042799 | Molecular function | histone H4K20 methyltransferase activity |
GO_0008270 | Molecular function | zinc ion binding |
GO_0050681 | Molecular function | nuclear androgen receptor binding |
GO_0140938 | Molecular function | histone H3 methyltransferase activity |
GO_0046975 | Molecular function | histone H3K36 methyltransferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | NSD1 |
Protein name | Truncated nuclear receptor binding SET domain protein 1 (EC 2.1.1.354) Truncated nuclear receptor binding SET domain protein 1 (EC 2.1.1.43) Nuclear receptor binding SET domain protein 1 NSD1 protein Alternative protein NSD1 Histone-lysine N-methyltransferase, H3 lysine-36 specific (EC 2.1.1.357) (Androgen receptor coactivator 267 kDa protein) (Androgen receptor-associated protein of 267 kDa) (H3-K36-HMTase) (Lysine N-methyltransferase 3B) (Nuclear receptor-binding SET domain-containing protein 1) (NR-binding SET domain-containing protein) Nuclear receptor SET domain-containing protein 1 |
Synonyms | KMT3B ARA267 |
Description | FUNCTION: Histone methyltransferase that dimethylates Lys-36 of histone H3 (H3K36me2). Transcriptional intermediary factor capable of both negatively or positively influencing transcription, depending on the cellular context. . |
Accessions | ENST00000439151.7 [Q96L73-1] A4QPE5 Q96L73 H7BYB0 ENST00000375350.3 A0A1W2PS55 L0R5C2 ENST00000689326.1 A0A6C0WF95 A0A2R8Y7J4 ENST00000508029.6 B2RWP5 ENST00000689345.1 D6RG26 ENST00000354179.9 ENST00000687453.1 [Q96L73-3] ENST00000686993.1 ENST00000511258.6 A0A8I5KV31 ENST00000347982.9 D6RBP3 ENST00000638627.3 A0A8I5QJP2 A0A3G1LEI2 ENST00000644863.2 A0A410SEU7 ENST00000503056.6 ENST00000508896.7 L8EAB5 |